Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Prediabetes

1-methyl-3-isobutylxanthine has been researched along with Prediabetes in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MC1
Proost, P1
Gysemans, C1
Mathieu, C1
Eizirik, DL1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Prediabetes

ArticleYear
Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
    Diabetologia, 2001, Volume: 44, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cells, Cultured; Chemokine CCL2; Diabetes Mellitus, Type 1; Fe

2001